Revvity Inc.RVTY
▼ NegativeCapitalrelevance
Second-quarter profit fell to $51.8 million from $53.9 million, with adjusted EPS of $1.41.
Impact on stocks 1
Biotech & Genomic Medicine
Revvity Inc.Revvity, Inc. reported a drop in second-quarter profit. The company's bottom line totaled $51.820 million, or $0.47 per share, compared with $53.948 million, or $0.51 per share, in the same period last year. Excluding items, adjusted earnings were $1.41 per share. Revenue rose 1.3% to $729.688 million from $720.284 million a year earlier.
Revvity Inc.Second-quarter profit fell to $51.8 million from $53.9 million, with adjusted EPS of $1.41.